Vivus Initiated at Buy and 3 Analyst-Initiated Shares to Watch
September 24, 2012
Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on September 24th.
Alexion Pharma (NASDAQ:ALXN): Canaccord Genuity initiated coverage of this company with a rating of Buy and a price target of $115 >> $132.
Don’t Miss: Can Apple Hit This Magic Number?
CBS (NYSE:CBS): The Benchmark Company initiated coverage of this company with a rating of Buy and a price target of $39 >> $44.
Vivus (NASDAQ:VVUS): Needham initiated coverage of this company with a rating of Buy and a price target of $38 >> $32.
Salesforce.com (NYSE:CRM): Needham initiated coverage of this company with a rating of Buy and a price target of $160 >> $180.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Wall St. Cheat Sheet has been featured in these fine media outlets:
